name:-0.12298917770386
name:-0.033032894134521
name:-0.01384711265564
Aphios Corporation Patent Filings

Aphios Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aphios Corporation.The latest application filed is for "bryoid compositions, methods of making and use thereof".

Company Profile
19.30.39
  • Aphios Corporation - Woburn MA
  • Aphios Corporation -
  • Aphios Corporation; - Woburn MA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Bryoid Compositions, Methods Of Making And Use Thereof
App 20220296522 - Castor; Trevor Percival
2022-09-22
Nanoencapsulated Cannabidiol
App 20220288059 - Castor; Trevor Percival
2022-09-15
Combination Therapeutics And Methods For The Treatment Of Neurodegenerative And Other Diseases
App 20220142934 - Castor; Trevor Percival
2022-05-12
Combination HIV therapeutic
Grant 11,234,932 - Castor February 1, 2
2022-02-01
Methods And Products For Treating Folic Acid Deficiency And Morning Sickness
App 20220016120 - Castor; Trevor P
2022-01-20
Superfluids Disruption Of Saccharomyces Cerevisiae (yeast), Cell Wall Disintegration Into Nanoparticles And Fractionation Into Beta-glucans, Chitin And Mannans (mannoproteins)
App 20220010263 - Castor; Trevor Percival
2022-01-13
Bryoid Compositions, Methods of Making and Use Thereof
App 20210269453 - Castor; Trevor Percival
2021-09-02
Bryoid compositions, methods of making and use thereof
Grant 10,954,248 - Castor March 23, 2
2021-03-23
Drug delivery system and method for the treatment of neuro-degenerative disease
App 20200397701 - Castor; Trevor Percival ;   et al.
2020-12-24
Combination therapeutics and methods for the treatment of neurodegenerative and other diseases
Grant 10,828,276 - Castor November 10, 2
2020-11-10
Transplantation therapies
Grant 10,723,744 - Alexander , et al.
2020-07-28
Transplantation Therapies
App 20200199146A1 -
2020-06-25
Transplantation Therapies
App 20200199145A1 -
2020-06-25
Combination Hiv Therapeutic
App 20200093742 - Castor; Trevor Percival
2020-03-26
Combination HIV therapeutic
Grant 10,493,030 - Castor De
2019-12-03
Drug delivery system and method for the treatment of neuro-degenerative disease
Grant 10,485,766 - Castor , et al. Nov
2019-11-26
Bryoid Compositions, Methods Of Making And Use Thereof
App 20190194222 - Castor; Trevor Percival
2019-06-27
Formulations and compositions of vitamin D analogs for treating and preventing cancer and other diseases
Grant 10,258,635 - Castor
2019-04-16
Transplantation Therapies
App 20180291033 - Alexander; Jonathan Steven ;   et al.
2018-10-11
Apparatus And Methods For Making Nanosomes Loaded With Nucleic Acid
App 20180272307 - Castor; Trevor Percival
2018-09-27
Transplantation therapies
Grant 9,994,585 - Alexander , et al. June 12, 2
2018-06-12
Apparatus and methods for making nanosomes loaded with nucleic acid
Grant 9,981,238 - Castor May 29, 2
2018-05-29
Combination Hiv Therapeutic
App 20180133155 - Castor; Trevor Percival
2018-05-17
Formulations and Compositions of Vitamin D Analogs for Treating and Preventing Cancer and other Diseases
App 20160184329 - Castor; Trevor P.
2016-06-30
Formulations And Compositions Of Vitamin D Analogs For Treating And Preventing Cancer And Other Diseases
App 20160008377 - Castor; Trevor P.
2016-01-14
Combination Therapeutics And Methods For The Treatment Of Neurodegenerative And Other Diseases
App 20150297555 - CASTOR; Trevor Percival
2015-10-22
Bryoid Compositions, Methods Of Making And Use Thereof
App 20150291616 - Castor; Trevor Percival
2015-10-15
Drug Delivery System And Method For The Treatment Of Neuro-degenerative Disease
App 20150246000 - Castor; Trevor Percival ;   et al.
2015-09-03
Drug delivery system and method for the treatment of neuro-degenerative disease
Grant 9,034,347 - Castor , et al. May 19, 2
2015-05-19
Transplantation Therapies
App 20150094363 - Alexander; Jonathan Steven ;   et al.
2015-04-02
Nanotechnology formulation of poorly soluble compounds
Grant 8,703,727 - Castor April 22, 2
2014-04-22
Methods, Kits And Compositions For Inactivation Of Viral Agents In Whole Blood And Red Blood Cell Concentrates
App 20140080114 - CASTOR; Trevor Percival ;   et al.
2014-03-20
Methods for co-encapsulation of combination drugs and co-encapsulated combination drug product
Grant 8,637,074 - Castor January 28, 2
2014-01-28
Nanoencapsulated delta-9-tetrahydrocannabinol
Grant 8,629,177 - Castor , et al. January 14, 2
2014-01-14
Methods and apparatus for processing cellulosic biomass
Grant 8,540,847 - Castor September 24, 2
2013-09-24
Drug Delivery System And Method For The Treatment Of Neuro-degenerative Disease
App 20130156822 - CASTOR; Trevor Percival
2013-06-20
Dosage Form, And Methods Of Making And Using The Same, To Produce Immunization In Animals And Humans
App 20130122106 - CASTOR; Trevor Percival
2013-05-16
Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
Grant 8,440,614 - Castor May 14, 2
2013-05-14
Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy
Grant 8,435,575 - Castor May 7, 2
2013-05-07
Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
Grant 8,070,467 - Castor December 6, 2
2011-12-06
Combination therapy comprising the use of protein kinase C modulators and Histone Deacetylase inhibitors for treating HIV-1 latency
App 20100166806 - Castor; Trevor Percival
2010-07-01
Pretreating cellulosic biomass
App 20090288788 - Castor; Trevor Percival
2009-11-26
COMPOSITIONS AND METHODS FOR INHIBITING 5-a REDUCTASE
App 20080241284 - Castor; Trevor P.
2008-10-02
Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein
Grant 7,147,806 - Castor December 12, 2
2006-12-12
Compositions, methods and apparatus for supercritical fluid virus inactivation
App 20060269928 - Castor; Trevor Percival
2006-11-30
Formulations for hyperforin-enriched hypericum fractions
App 20060240098 - Castor; Trevor P.
2006-10-26
Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds
Grant 7,037,534 - Castor , et al. May 2, 2
2006-05-02
Polymer Microspheres/nanospheres And Encapsulating Therapeutic Proteins Therein
App 20060033224 - Castor; Trevor P.
2006-02-16
Compositions and methods for inhibiting 5-alpha reductase
App 20050118282 - Castor, Trevor P.
2005-06-02
Compositions and methods for reducing dental plaque
App 20050106111 - Castor, Trevor P.
2005-05-19
Compositions and methods for topically treating diseases
App 20050095283 - Castor, Trevor P. ;   et al.
2005-05-05
Compositions and methods for treating and preventing cancer using analogs of vitamin D
App 20050059641 - Ray, Rahul ;   et al.
2005-03-17
Viral inactivation method using near critical, supercritical or critical fluids
Grant 5,877,005 - Castor , et al. March 2, 1
1999-03-02
Methods and apparatus for making liposomes containing hydrophobic drugs
Grant 5,776,486 - Castor , et al. July 7, 1
1998-07-07
Method and apparatus for isolating therapeutic compositions from source materials
Grant 5,750,709 - Castor May 12, 1
1998-05-12
Methods and apparatus for making liposomes
Grant 5,554,382 - Castor September 10, 1
1996-09-10
Method and apparatus for extracting taxol from source materials
Grant 5,440,055 - Castor August 8, 1
1995-08-08
Supercritical fluid disruption of and extraction from microbial cells
Grant 5,380,826 - Castor , et al. Ja
1995-01-10
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed